Batinic, A.; Sutlović, D.; Kuret, S.; Matana, A.; Kumric, M.; Bozic, J.; Dujic, Z.
Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study. Pharmaceuticals 2023, 16, 645.
https://doi.org/10.3390/ph16050645
AMA Style
Batinic A, Sutlović D, Kuret S, Matana A, Kumric M, Bozic J, Dujic Z.
Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study. Pharmaceuticals. 2023; 16(5):645.
https://doi.org/10.3390/ph16050645
Chicago/Turabian Style
Batinic, Ana, Davorka Sutlović, Sendi Kuret, Antonela Matana, Marko Kumric, Josko Bozic, and Zeljko Dujic.
2023. "Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study" Pharmaceuticals 16, no. 5: 645.
https://doi.org/10.3390/ph16050645
APA Style
Batinic, A., Sutlović, D., Kuret, S., Matana, A., Kumric, M., Bozic, J., & Dujic, Z.
(2023). Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study. Pharmaceuticals, 16(5), 645.
https://doi.org/10.3390/ph16050645
